| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 7.419.184.332 $ | 99,79 | 369.115.438 | |||||||
| Apellis Pharmaceuticals Inc | Apellis Pharmaceuticals Inc | EC | 03753U106 | Long | Börsenkurs (Stufe 1) | 136.397.964 $ | 1,83 | 3.390.454 | |
| Alkermes PLC | Alkermes PLC | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 107.877.349 $ | 1,45 | 3.050.830 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 102.813.696 $ | 1,38 | 196.408 | |
| TG Therapeutics Inc | TG Therapeutics Inc | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 100.334.399 $ | 1,35 | 3.020.301 | |
| Insmed Inc | Insmed Inc | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 99.394.814 $ | 1,34 | 607.845 | |
| Scholar Rock Holding Corp | Scholar Rock Holding Corp | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 96.450.199 $ | 1,30 | 1.961.965 | |
| Apogee Therapeutics Inc | Apogee Therapeutics Inc | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 95.481.943 $ | 1,28 | 1.134.394 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics Inc | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 92.548.683 $ | 1,24 | 878.071 | |
| Summit Therapeutics Inc | Summit Therapeutics Inc | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 92.267.854 $ | 1,24 | 4.866.448 | |
| United Therapeutics Corp | United Therapeutics Corp | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 92.226.179 $ | 1,24 | 155.530 | |
| Praxis Precision Medicines Inc | Praxis Precision Medicines Inc | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 91.905.342 $ | 1,24 | 285.252 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 91.429.579 $ | 1,23 | 1.458.207 | |
| Cogent Biosciences Inc | Cogent Biosciences Inc | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 90.378.407 $ | 1,22 | 2.348.101 | |
| Bridgebio Pharma Inc | Bridgebio Pharma Inc | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 88.132.956 $ | 1,19 | 1.186.816 | |
| PTC Therapeutics Inc | PTC Therapeutics Inc | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 87.892.537 $ | 1,18 | 1.290.071 | |
| Cytokinetics Inc | Cytokinetics Inc | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 87.756.067 $ | 1,18 | 1.331.453 | |
| Alnylam Pharmaceuticals Inc | Alnylam Pharmaceuticals Inc | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 87.484.013 $ | 1,18 | 264.406 | |
| Exelixis Inc | Exelixis Inc | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 87.033.031 $ | 1,17 | 2.029.215 | |
| Nuvalent Inc | Nuvalent Inc | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 86.751.382 $ | 1,17 | 846.768 | |
| Kymera Therapeutics Inc | Kymera Therapeutics Inc | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 86.561.631 $ | 1,16 | 1.039.280 | |
| CG oncology Inc | CG oncology Inc | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 86.421.946 $ | 1,16 | 1.276.920 | |
| Natera Inc | Natera Inc | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 86.182.291 $ | 1,16 | 430.933 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 86.163.757 $ | 1,16 | 654.044 | |
| Twist Bioscience Corp | Twist Bioscience Corp | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 85.917.871 $ | 1,16 | 1.808.036 | |
| Krystal Biotech Inc | Krystal Biotech Inc | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 85.833.795 $ | 1,15 | 332.277 | |
| Vaxcyte Inc | Vaxcyte Inc | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 85.579.469 $ | 1,15 | 1.472.715 | |
| Mirum Pharmaceuticals Inc | Mirum Pharmaceuticals Inc | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 85.310.436 $ | 1,15 | 923.473 | |
| Amicus Therapeutics Inc | Amicus Therapeutics Inc | EC | 03152W109 | Long | Börsenkurs (Stufe 1) | 85.251.388 $ | 1,15 | 5.895.670 | |
| Ionis Pharmaceuticals Inc | Ionis Pharmaceuticals Inc | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 85.069.912 $ | 1,14 | 1.132.906 | |
| Travere Therapeutics Inc | Travere Therapeutics Inc | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 85.065.434 $ | 1,14 | 2.863.192 | |
| Arcellx Inc | Arcellx Inc | EC | 03940C100 | Long | Börsenkurs (Stufe 1) | 85.056.934 $ | 1,14 | 740.785 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 84.526.816 $ | 1,14 | 109.400 | |
| Incyte Corp | Incyte Corp | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 84.238.624 $ | 1,13 | 895.013 | |
| Celcuity Inc | Celcuity Inc | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 83.541.920 $ | 1,12 | 731.925 | |
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 82.737.188 $ | 1,11 | 850.768 | |
| Halozyme Therapeutics Inc | Halozyme Therapeutics Inc | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 82.370.224 $ | 1,11 | 1.274.489 | |
| Rhythm Pharmaceuticals Inc | Rhythm Pharmaceuticals Inc | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 81.852.859 $ | 1,10 | 941.162 | |
| Biogen Inc | Biogen Inc | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 81.555.267 $ | 1,10 | 444.855 | |
| Arcutis Biotherapeutics Inc | Arcutis Biotherapeutics Inc | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 80.994.686 $ | 1,09 | 3.437.805 | |
| AbbVie Inc | AbbVie Inc | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 80.928.681 $ | 1,09 | 372.103 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 80.871.394 $ | 1,09 | 580.264 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 80.716.824 $ | 1,09 | 1.696.801 | |
| BioMarin Pharmaceutical Inc | BioMarin Pharmaceutical Inc | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 79.345.910 $ | 1,07 | 1.404.601 | |
| Roivant Sciences Ltd | Roivant Sciences Ltd | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 79.339.365 $ | 1,07 | 2.864.237 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 79.006.510 $ | 1,06 | 224.546 | |
| ImmunityBio Inc | ImmunityBio Inc | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 78.571.672 $ | 1,06 | 10.244.025 | |
| Beam Therapeutics Inc | Beam Therapeutics Inc | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 77.414.758 $ | 1,04 | 3.248.626 | |
| Viking Therapeutics Inc | Viking Therapeutics Inc | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 77.093.410 $ | 1,04 | 2.369.189 | |
| Vera Therapeutics Inc | Vera Therapeutics Inc | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 76.921.932 $ | 1,03 | 1.912.054 | |
| Moderna Inc | Moderna Inc | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 76.896.976 $ | 1,03 | 1.513.720 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 76.839.710 $ | 1,03 | 172.078 | |
| Erasca Inc | Erasca Inc | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 76.581.461 $ | 1,03 | 4.733.094 | |
| ACADIA Pharmaceuticals Inc | ACADIA Pharmaceuticals Inc | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 75.965.700 $ | 1,02 | 3.412.655 | |
| Sarepta Therapeutics Inc | Sarepta Therapeutics Inc | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 66.520.973 $ | 0,89 | 3.057.030 | |
| Agios Pharmaceuticals Inc | Agios Pharmaceuticals Inc | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 65.302.861 $ | 0,88 | 1.930.324 | |
| Ultragenyx Pharmaceutical Inc | Ultragenyx Pharmaceutical Inc | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 65.109.185 $ | 0,88 | 3.107.837 | |
| Disc Medicine Inc | Disc Medicine Inc | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 64.710.349 $ | 0,87 | 1.012.048 | |
| Immunome Inc | Immunome Inc | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 64.184.120 $ | 0,86 | 2.934.802 | |
| Immunovant Inc | Immunovant Inc | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 63.752.556 $ | 0,86 | 2.566.528 | |
| BioCryst Pharmaceuticals Inc | BioCryst Pharmaceuticals Inc | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 63.356.114 $ | 0,85 | 6.655.054 | |
| Veracyte Inc | Veracyte Inc | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 63.056.905 $ | 0,85 | 1.957.681 | |
| Dyne Therapeutics Inc | Dyne Therapeutics Inc | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 62.322.310 $ | 0,84 | 3.437.524 | |
| Catalyst Pharmaceuticals Inc | Catalyst Pharmaceuticals Inc | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 56.162.910 $ | 0,76 | 2.268.292 | |
| Syndax Pharmaceuticals Inc | Syndax Pharmaceuticals Inc | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 54.736.942 $ | 0,74 | 2.343.191 | |
| Denali Therapeutics Inc | Denali Therapeutics Inc | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 54.352.397 $ | 0,73 | 2.830.854 | |
| Ideaya Biosciences Inc | Ideaya Biosciences Inc | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 54.269.150 $ | 0,73 | 1.628.726 | |
| Spyre Therapeutics Inc | Spyre Therapeutics Inc | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 53.948.405 $ | 0,73 | 1.069.556 | |
| GRAIL Inc | GRAIL Inc | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 53.814.126 $ | 0,72 | 1.041.295 | |
| Viridian Therapeutics Inc | Viridian Therapeutics Inc | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 52.166.657 $ | 0,70 | 2.667.007 | |
| Recursion Pharmaceuticals Inc | Recursion Pharmaceuticals Inc | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 51.368.809 $ | 0,69 | 16.732.511 | |
| Kodiak Sciences Inc | Kodiak Sciences Inc | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 51.239.036 $ | 0,69 | 1.344.151 | |
| Soleno Therapeutics Inc | Soleno Therapeutics Inc | EC | 834203309 | Long | Börsenkurs (Stufe 1) | 50.088.691 $ | 0,67 | 1.496.078 | |
| Dianthus Therapeutics Inc | Dianthus Therapeutics Inc | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 49.233.598 $ | 0,66 | 586.673 | |
| Intellia Therapeutics Inc | Intellia Therapeutics Inc | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 48.117.729 $ | 0,65 | 3.753.333 | |
| Mineralys Therapeutics Inc | Mineralys Therapeutics Inc | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 48.037.288 $ | 0,65 | 1.773.248 | |
| Arcus Biosciences Inc | Arcus Biosciences Inc | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 46.728.641 $ | 0,63 | 2.163.363 | |
| Ardelyx Inc | Ardelyx Inc | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 45.910.044 $ | 0,62 | 7.664.448 | |
| ADMA Biologics Inc | ADMA Biologics Inc | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 44.293.989 $ | 0,60 | 4.916.092 | |
| Nurix Therapeutics Inc | Nurix Therapeutics Inc | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 43.553.094 $ | 0,59 | 2.809.877 | |
| Tango Therapeutics Inc | Tango Therapeutics Inc | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 41.266.185 $ | 0,56 | 1.972.571 | |
| Celldex Therapeutics Inc | Celldex Therapeutics Inc | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 38.777.066 $ | 0,52 | 1.222.480 | |
| Novavax Inc | Novavax Inc | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 37.995.200 $ | 0,51 | 4.667.715 | |
| Oruka Therapeutics Inc | Oruka Therapeutics Inc | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 37.328.669 $ | 0,50 | 761.033 | |
| Olema Pharmaceuticals Inc | Olema Pharmaceuticals Inc | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 36.855.716 $ | 0,50 | 2.471.879 | |
| Stoke Therapeutics Inc | Stoke Therapeutics Inc | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 36.651.880 $ | 0,49 | 1.125.672 | |
| Vericel Corp | Vericel Corp | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 35.909.827 $ | 0,48 | 1.116.252 | |
| Capricor Therapeutics Inc | Capricor Therapeutics Inc | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 35.625.578 $ | 0,48 | 1.171.894 | |
| Palvella Therapeutics Inc | Palvella Therapeutics Inc | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 34.183.019 $ | 0,46 | 274.232 | |
| Biohaven Ltd | Biohaven Ltd | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 32.526.010 $ | 0,44 | 3.844.682 | |
| Monte Rosa Therapeutics Inc | Monte Rosa Therapeutics Inc | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 32.352.725 $ | 0,44 | 1.966.731 | |
| Corvus Pharmaceuticals Inc | Corvus Pharmaceuticals Inc | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 30.969.633 $ | 0,42 | 2.116.858 | |
| Iovance Biotherapeutics Inc | Iovance Biotherapeutics Inc | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 28.570.954 $ | 0,38 | 8.139.873 | |
| AnaptysBio Inc | AnaptysBio Inc | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 28.405.226 $ | 0,38 | 512.175 | |
| Relay Therapeutics Inc | Relay Therapeutics Inc | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 28.174.808 $ | 0,38 | 2.831.639 | |
| uniQure NV | uniQure NV | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 27.752.523 $ | 0,37 | 1.697.402 | |
| ORIC Pharmaceuticals Inc | ORIC Pharmaceuticals Inc | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 27.513.057 $ | 0,37 | 2.171.512 | |
| MannKind Corp | MannKind Corp | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 26.787.460 $ | 0,36 | 10.933.657 | |
| CareDx Inc | CareDx Inc | EC | 14167L103 | Long | Börsenkurs (Stufe 1) | 25.700.074 $ | 0,35 | 1.480.419 | |
| Taysha Gene Therapies Inc | Taysha Gene Therapies Inc | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 25.205.932 $ | 0,34 | 5.638.911 | |
| Tyra Biosciences Inc | Tyra Biosciences Inc | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 25.104.003 $ | 0,34 | 655.457 | |
| Geron Corp | Geron Corp | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 24.754.403 $ | 0,33 | 16.613.693 | |
| Day One Biopharmaceuticals Inc | Day One Biopharmaceuticals Inc | EC | 23954D109 | Long | Börsenkurs (Stufe 1) | 23.871.317 $ | 0,32 | 1.113.401 | |
| Precigen Inc | Precigen Inc | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 23.238.553 $ | 0,31 | 6.004.794 | |
| Vir Biotechnology Inc | Vir Biotechnology Inc | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 22.649.043 $ | 0,30 | 2.527.795 | |
| KalVista Pharmaceuticals Inc | KalVista Pharmaceuticals Inc | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 21.699.174 $ | 0,29 | 1.077.952 | |
| CytomX Therapeutics Inc | CytomX Therapeutics Inc | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 21.201.869 $ | 0,29 | 4.511.036 | |
| Annexon Inc | Annexon Inc | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 21.181.459 $ | 0,28 | 3.823.368 | |
| Kura Oncology Inc | Kura Oncology Inc | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 20.513.860 $ | 0,28 | 2.523.230 | |
| Inhibrx Biosciences Inc | Inhibrx Biosciences Inc | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 19.939.141 $ | 0,27 | 296.581 | |
| SELLAS Life Sciences Group Inc | SELLAS Life Sciences Group Inc | EC | 81642T209 | Long | Börsenkurs (Stufe 1) | 19.837.896 $ | 0,27 | 4.689.810 | |
| Janux Therapeutics Inc | Janux Therapeutics Inc | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 19.801.106 $ | 0,27 | 1.424.540 | |
| Compass Therapeutics Inc | Compass Therapeutics Inc | EC | 20454B104 | Long | Börsenkurs (Stufe 1) | 19.493.592 $ | 0,26 | 3.684.989 | |
| Savara Inc | Savara Inc | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 19.410.136 $ | 0,26 | 3.554.970 | |
| Rigel Pharmaceuticals Inc | Rigel Pharmaceuticals Inc | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 19.165.303 $ | 0,26 | 708.776 | |
| Sana Biotechnology Inc | Sana Biotechnology Inc | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 19.153.368 $ | 0,26 | 6.650.475 | |
| Cullinan Therapeutics Inc | Cullinan Therapeutics Inc | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 18.579.021 $ | 0,25 | 1.307.461 | |
| ARS Pharmaceuticals Inc | ARS Pharmaceuticals Inc | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 17.774.453 $ | 0,24 | 2.213.506 | |
| Zenas Biopharma Inc | Zenas Biopharma Inc | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 17.717.285 $ | 0,24 | 906.255 | |
| Xencor Inc | Xencor Inc | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 17.151.286 $ | 0,23 | 1.422.163 | |
| Replimune Group Inc | Replimune Group Inc | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 16.817.653 $ | 0,23 | 2.198.386 | |
| Sionna Therapeutics Inc | Sionna Therapeutics Inc | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 16.702.697 $ | 0,22 | 416.630 | |
| Vor BioPharma Inc | Vor BioPharma Inc | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 16.634.016 $ | 0,22 | 932.400 | |
| ArriVent Biopharma Inc | ArriVent Biopharma Inc | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 16.174.100 $ | 0,22 | 701.088 | |
| Ironwood Pharmaceuticals Inc | Ironwood Pharmaceuticals Inc | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 14.037.276 $ | 0,19 | 3.999.224 | |
| Bicara Therapeutics Inc | Bicara Therapeutics Inc | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 13.955.679 $ | 0,19 | 701.643 | |
| Prime Medicine Inc | Prime Medicine Inc | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 13.850.376 $ | 0,19 | 3.979.993 | |
| Altimmune Inc | Altimmune Inc | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 13.407.520 $ | 0,18 | 4.353.091 | |
| Absci Corp | Absci Corp | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 13.345.359 $ | 0,18 | 4.448.453 | |
| Emergent BioSolutions Inc | Emergent BioSolutions Inc | EC | 29089Q105 | Long | Börsenkurs (Stufe 1) | 13.055.278 $ | 0,18 | 1.572.925 | |
| Allogene Therapeutics Inc | Allogene Therapeutics Inc | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 12.718.759 $ | 0,17 | 5.212.606 | |
| Hyperliquid Strategies Inc | Hyperliquid Strategies Inc | EC | 44916Y106 | Long | Börsenkurs (Stufe 1) | 12.477.300 $ | 0,17 | 2.451.336 | |
| 4D Molecular Therapeutics Inc | 4D Molecular Therapeutics Inc | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 12.271.213 $ | 0,17 | 1.318.068 | |
| Vanda Pharmaceuticals Inc | Vanda Pharmaceuticals Inc | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 11.774.854 $ | 0,16 | 1.704.031 | |
| REGENXBIO Inc | REGENXBIO Inc | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 11.428.728 $ | 0,15 | 1.363.810 | |
| Lexeo Therapeutics Inc | Lexeo Therapeutics Inc | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 10.691.938 $ | 0,14 | 1.862.707 | |
| Verastem Inc | Verastem Inc | EC | 92337C203 | Long | Börsenkurs (Stufe 1) | 10.676.845 $ | 0,14 | 2.014.499 | |
| Arbutus Biopharma Corp | Arbutus Biopharma Corp | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 10.206.293 $ | 0,14 | 2.268.065 | |
| Myriad Genetics Inc | Myriad Genetics Inc | EC | 62855J104 | Long | Börsenkurs (Stufe 1) | 9.721.445 $ | 0,13 | 2.160.321 | |
| Prothena Corp PLC | Prothena Corp PLC | EC | IE00B91XRN20 | Long | Börsenkurs (Stufe 1) | 9.559.115 $ | 0,13 | 983.448 | |
| Ocugen Inc | Ocugen Inc | EC | 67577C105 | Long | Börsenkurs (Stufe 1) | 9.453.302 $ | 0,13 | 5.222.819 | |
| Rocket Pharmaceuticals Inc | Rocket Pharmaceuticals Inc | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 9.332.996 $ | 0,13 | 2.606.982 | |
| MiMedx Group Inc | MiMedx Group Inc | EC | 602496101 | Long | Börsenkurs (Stufe 1) | 9.016.507 $ | 0,12 | 2.282.660 | |
| Akebia Therapeutics Inc | Akebia Therapeutics Inc | EC | 00972D105 | Long | Börsenkurs (Stufe 1) | 8.394.206 $ | 0,11 | 6.038.997 | |
| Anavex Life Sciences Corp | Anavex Life Sciences Corp | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 8.147.421 $ | 0,11 | 2.653.883 | |
| Invivyd Inc | Invivyd Inc | EC | 00534A102 | Long | Börsenkurs (Stufe 1) | 7.351.013 $ | 0,10 | 5.654.625 | |
| Perspective Therapeutics Inc | Perspective Therapeutics Inc | EC | 46489V302 | Long | Börsenkurs (Stufe 1) | 7.145.274 $ | 0,10 | 1.713.495 | |
| Damora Therapeutics Inc | Damora Therapeutics Inc | EC | 36322Q206 | Long | Börsenkurs (Stufe 1) | 2.429.342 $ | 0,03 | 93.797 | |
| OMNIAB INC | OMNIAB INC | EC | 68218J301 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 323.918 | |
| 7.419.184.332 $ | 99,79 | 369.115.438 |